Search Results
Record - 1
TI: Time to review the way we estimate access to haemophilia concentrates worldwide
AU: Farrugia, A.
JN: Haemophilia
PD: 20170501
VO: 23
NO: 3
PG: e235-e237(3)
PB: Wiley-Blackwell
DOI: 10.1111/hae.13223
IS: 1351-8216
Record - 2
TI: Regulatory oversight of cellular therapies
AU: Farrugia, A.
JN: ISBT Science Series
PD: 20071101
VO: 2
NO: 2
PG: 141-146(6)
PB: Wiley-Blackwell
DOI: 10.1111/j.1751-2824.2007.00130.x
IS: 1751-2816
Record - 3
TI: Globalization and blood safety
AU: Farrugia, A.
JN: ISBT Science Series
PD: 20060901
VO: 1
NO: 1
PG: 25-32(8)
PB: Wiley-Blackwell
DOI: 10.1111/j.1751-2824.2006.00007.x
IS: 1751-2816
Record - 4
TI: Evolving perspectives in product safety for haemophilia
AU: FARRUGIA, A.
JN: Haemophilia
PD: 20020501
VO: 8
NO: 3
PG: 236-243(8)
PB: Wiley-Blackwell
DOI: 10.1046/j.1365-2516.2002.00596.x
KY: haemophilia, product safety
IS: 1351-8216
Record - 5
TI: Risk of variant Creuzfeldt–Jakob disease from factor concentrates: current perspectives
AU: FARRUGIA, A.
JN: Haemophilia
PD: 20020501
VO: 8
NO: 3
PG: 230-235(6)
PB: Wiley-Blackwell
DOI: 10.1046/j.1365-2516.2002.00618.x
KY: factor concentrates, haemophilia, transmissible spongiform encephalopathies, variant Creutzfeldt–Jakob disease
IS: 1351-8216
Record - 6
TI: Plasma for fractionation: safety and quality issues
AU: Farrugia, A.
JN: Haemophilia
PD: 20040701
VO: 10
NO: 4
PG: 334-340(7)
PB: Wiley-Blackwell
DOI: 10.1111/j.1365-2516.2004.00911.x
KY: plasma, products, safety
IS: 1351-8216
Record - 7
TI: Safety and supply of haemophilia products: worldwide perspectives
AU: Farrugia, A.
JN: Haemophilia
PD: 20040701
VO: 10
NO: 4
PG: 327-333(7)
PB: Wiley-Blackwell
DOI: 10.1111/j.1365-2516.2004.00910.x
KY: products, concentrates, safety, therapy
IS: 1351-8216
Record - 8
TI: Product delivery in the developing world: options, opportunities and threats
AU: Farrugia, A.
JN: Haemophilia
PD: 20041001
VO: 10
NO: 1
PG: 77-82(6)
PB: Wiley-Blackwell
DOI: 10.1111/j.1365-2516.2004.01007.x
KY: access, blood products, manufacture, safety, self-sufficiency
IS: 1351-8216
Record - 9
TI: Regulatory challenges to global harmonization and expanded access to concentrates: how will regulators balance the increasing cost of new safety requirements with the desire to increase the availability of affordable product?
AU: Farrugia, A.
JN: Haemophilia
PD: 20041001
VO: 10
NO: 1
PG: 83-87(5)
PB: Wiley-Blackwell
DOI: 10.1111/j.1365-2516.2004.01040.x
KY: access, regulation, safety
IS: 1351-8216
Record - 10
TI: Falsification or paradigm shift? Toward a revision of the common sense of transfusion
AU: Farrugia, Albert
JN: Transfusion
PD: 20110101
VO: 51
NO: 1
PG: 216-224(9)
PB: Wiley-Blackwell
DOI: 10.1111/j.1537-2995.2010.02817.x
IS: 0041-1132
Copyright Mon Jul 17 16:26:12 UTC 2017 Ingenta Connect